APO Research

APO RESEARCH · REPORT

Sufentanil Citrate Injection

Selected research

Market Structure

Global Sufentanil Citrate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Sufentanil Citrate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sufentanil Citrate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sufentanil Citrate Injection include Akorn, EuroCept B.V., hameln pharma gmbh, Hikma Pharmaceuticals USA, IDT Biologika GmBH, Pfizer, Piramal Critical Care Limited, Nhwa Pharmaceutical and Sinopharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sufentanil Citrate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sufentanil Citrate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sufentanil Citrate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sufentanil Citrate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Sufentanil Citrate Injection Segment by Company

Akorn

EuroCept B.V.

hameln pharma gmbh

Hikma Pharmaceuticals USA

IDT Biologika GmBH

Pfizer

Piramal Critical Care Limited

Nhwa Pharmaceutical

Sinopharm

Humanwell Pharmaceutical

Sufentanil Citrate Injection Segment by Type

5ml

2ml

1ml

10ml

Sufentanil Citrate Injection Segment by Application

Hospital

Clinic

Others

Sufentanil Citrate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil Citrate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil Citrate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil Citrate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sufentanil Citrate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sufentanil Citrate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sufentanil Citrate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sufentanil Citrate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sufentanil Citrate Injection Industry Trends Table 2. Sufentanil Citrate Injection Industry Drivers Table 3. Sufentanil Citrate Injection Industry Opportunities and Challenges Table 4. Sufentanil Citrate Injection Industry Restraints Table 5. Global Sufentanil Citrate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sufentanil Citrate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sufentanil Citrate Injection Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Sufentanil Citrate Injection Sales Market Share by Manufacturers Table 9. Global Sufentanil Citrate Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sufentanil Citrate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sufentanil Citrate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sufentanil Citrate Injection Manufacturers, Product Type & Application Table 13. Global Sufentanil Citrate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sufentanil Citrate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5ml Table 17. Major Manufacturers of 2ml Table 18. Major Manufacturers of 1ml Table 19. Major Manufacturers of 10ml Table 20. Global Sufentanil Citrate Injection Sales by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Sufentanil Citrate Injection Sales by Type (2021-2026) & (Units) Table 22. Global Sufentanil Citrate Injection Sales by Type (2027-2032) & (Units) Table 23. Global Sufentanil Citrate Injection Sales Market Share by Type (2021-2026) Table 24. Global Sufentanil Citrate Injection Sales Market Share by Type (2027-2032) Table 25. Global Sufentanil Citrate Injection Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 26. Global Sufentanil Citrate Injection Revenue by Type (2021-2026) & (Units) Table 27. Global Sufentanil Citrate Injection Revenue by Type (2027-2032) & (Units) Table 28. Global Sufentanil Citrate Injection Revenue Market Share by Type (2021-2026) Table 29. Global Sufentanil Citrate Injection Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Sufentanil Citrate Injection Sales by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Sufentanil Citrate Injection Sales by Application (2021-2026) & (Units) Table 35. Global Sufentanil Citrate Injection Sales by Application (2027-2032) & (Units) Table 36. Global Sufentanil Citrate Injection Sales Market Share by Application (2021-2026) Table 37. Global Sufentanil Citrate Injection Sales Market Share by Application (2027-2032) Table 38. Global Sufentanil Citrate Injection Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 39. Global Sufentanil Citrate Injection Revenue by Application (2021-2026) & (Units) Table 40. Global Sufentanil Citrate Injection Revenue by Application (2027-2032) & (Units) Table 41. Global Sufentanil Citrate Injection Revenue Market Share by Application (2021-2026) Table 42. Global Sufentanil Citrate Injection Revenue Market Share by Application (2027-2032) Table 43. Global Sufentanil Citrate Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Sufentanil Citrate Injection Sales by Region (2021-2026) & (Units) Table 45. Global Sufentanil Citrate Injection Sales Market Share by Region (2021-2026) Table 46. Global Sufentanil Citrate Injection Sales Forecasted by Region (2027-2032) & (Units) Table 47. Global Sufentanil Citrate Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 49. North America Sufentanil Citrate Injection Sales by Country (2021-2026) & (Units) Table 50. North America Sufentanil Citrate Injection Sales by Country (2027-2032) & (Units) Table 51. Europe Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 52. Europe Sufentanil Citrate Injection Sales by Country (2021-2026) & (Units) Table 53. Europe Sufentanil Citrate Injection Sales by Country (2027-2032) & (Units) Table 54. Asia Pacific Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Asia Pacific Sufentanil Citrate Injection Sales by Country (2021-2026) & (Units) Table 56. Asia Pacific Sufentanil Citrate Injection Sales by Country (2027-2032) & (Units) Table 57. South America, Middle East and Africa Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 58. South America, Middle East and Africa Sufentanil Citrate Injection Sales by Country (2021-2026) & (Units) Table 59. South America, Middle East and Africa Sufentanil Citrate Injection Sales by Country (2027-2032) & (Units) Table 60. Global Sufentanil Citrate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Sufentanil Citrate Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Sufentanil Citrate Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Sufentanil Citrate Injection Revenue Market Share by Region (2021-2026) Table 64. Global Sufentanil Citrate Injection Revenue Market Share by Region (2027-2032) Table 65. Akorn Company Information Table 66. Akorn Business Overview Table 67. Akorn Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Akorn Sufentanil Citrate Injection Product Portfolio Table 69. Akorn Recent Development Table 70. EuroCept B.V. Company Information Table 71. EuroCept B.V. Business Overview Table 72. EuroCept B.V. Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. EuroCept B.V. Sufentanil Citrate Injection Product Portfolio Table 74. EuroCept B.V. Recent Development Table 75. hameln pharma gmbh Company Information Table 76. hameln pharma gmbh Business Overview Table 77. hameln pharma gmbh Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. hameln pharma gmbh Sufentanil Citrate Injection Product Portfolio Table 79. hameln pharma gmbh Recent Development Table 80. Hikma Pharmaceuticals USA Company Information Table 81. Hikma Pharmaceuticals USA Business Overview Table 82. Hikma Pharmaceuticals USA Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hikma Pharmaceuticals USA Sufentanil Citrate Injection Product Portfolio Table 84. Hikma Pharmaceuticals USA Recent Development Table 85. IDT Biologika GmBH Company Information Table 86. IDT Biologika GmBH Business Overview Table 87. IDT Biologika GmBH Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. IDT Biologika GmBH Sufentanil Citrate Injection Product Portfolio Table 89. IDT Biologika GmBH Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Sufentanil Citrate Injection Product Portfolio Table 94. Pfizer Recent Development Table 95. Piramal Critical Care Limited Company Information Table 96. Piramal Critical Care Limited Business Overview Table 97. Piramal Critical Care Limited Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Piramal Critical Care Limited Sufentanil Citrate Injection Product Portfolio Table 99. Piramal Critical Care Limited Recent Development Table 100. Nhwa Pharmaceutical Company Information Table 101. Nhwa Pharmaceutical Business Overview Table 102. Nhwa Pharmaceutical Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Nhwa Pharmaceutical Sufentanil Citrate Injection Product Portfolio Table 104. Nhwa Pharmaceutical Recent Development Table 105. Sinopharm Company Information Table 106. Sinopharm Business Overview Table 107. Sinopharm Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sinopharm Sufentanil Citrate Injection Product Portfolio Table 109. Sinopharm Recent Development Table 110. Humanwell Pharmaceutical Company Information Table 111. Humanwell Pharmaceutical Business Overview Table 112. Humanwell Pharmaceutical Sufentanil Citrate Injection Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Humanwell Pharmaceutical Sufentanil Citrate Injection Product Portfolio Table 114. Humanwell Pharmaceutical Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Sufentanil Citrate Injection Distributors List Table 118. Sufentanil Citrate Injection Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Sufentanil Citrate Injection Product Image Figure 2. Global Sufentanil Citrate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil Citrate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Sufentanil Citrate Injection Sales (2021-2032) & (Units) Figure 5. Global Sufentanil Citrate Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sufentanil Citrate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5ml Image Figure 9. 2ml Image Figure 10. 1ml Image Figure 11. 10ml Image Figure 12. Global Sufentanil Citrate Injection Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Sufentanil Citrate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Sufentanil Citrate Injection Sales Market Share by Type (2021-2032) Figure 15. Global Sufentanil Citrate Injection Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Sufentanil Citrate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Sufentanil Citrate Injection Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Sufentanil Citrate Injection Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Sufentanil Citrate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Sufentanil Citrate Injection Sales Market Share by Application (2021-2032) Figure 24. Global Sufentanil Citrate Injection Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 25. Global Sufentanil Citrate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Sufentanil Citrate Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 28. North America Sufentanil Citrate Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 30. Canada Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 31. Mexico Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 32. Europe Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 33. Europe Sufentanil Citrate Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 35. France Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 36. U.K. Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 37. Italy Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 38. Netherlands Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 39. Asia Pacific Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 40. Asia Pacific Sufentanil Citrate Injection Sales Market Share by Country (2021-2032) Figure 41. China Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 42. Japan Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 43. South Korea Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 44. Southeast Asia Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 45. India Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 46. Australia Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 47. South America, Middle East and Africa Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 48. South America, Middle East and Africa Sufentanil Citrate Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 50. South Africa Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 51. Saudi Arabia Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 52. Turkey Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 53. Argentina Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 54. UAE Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 55. Egypt Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 56. Chile Sufentanil Citrate Injection Sales and Growth Rate (2021-2032) & (Units) Figure 57. Global Sufentanil Citrate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Sufentanil Citrate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Sufentanil Citrate Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Sufentanil Citrate Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Sufentanil Citrate Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Sufentanil Citrate Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Sufentanil Citrate Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sufentanil Citrate Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml
  • 2ml
  • 1ml
  • 10ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Akorn
  • EuroCept B.V.
  • hameln pharma gmbh
  • Hikma Pharmaceuticals USA
  • IDT Biologika GmBH
  • Pfizer
  • Piramal Critical Care Limited
  • Nhwa Pharmaceutical
  • Sinopharm
  • Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sufentanil Citrate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sufentanil Citrate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sufentanil Citrate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sufentanil Citrate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sufentanil Citrate Injection Market Dynamics
  1. 2.1 Sufentanil Citrate Injection Industry Trends
  2. 2.2 Sufentanil Citrate Injection Industry Drivers
  3. 2.3 Sufentanil Citrate Injection Industry Opportunities and Challenges
  4. 2.4 Sufentanil Citrate Injection Industry Restraints
3 Sufentanil Citrate Injection Market by Manufacturers
  1. 3.1 Global Sufentanil Citrate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sufentanil Citrate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sufentanil Citrate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sufentanil Citrate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sufentanil Citrate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sufentanil Citrate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Sufentanil Citrate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sufentanil Citrate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sufentanil Citrate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sufentanil Citrate Injection Tier 1, Tier 2, and Tier 3
4 Sufentanil Citrate Injection Market by Type
  1. 4.1 Sufentanil Citrate Injection Type Introduction
  2. 4.1.1 5ml
  3. 4.1.2 2ml
  4. 4.1.3 1ml
  5. 4.1.4 10ml
  6. 4.2 Global Sufentanil Citrate Injection Sales by Type
  7. 4.2.1 Global Sufentanil Citrate Injection Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sufentanil Citrate Injection Sales by Type (2021-2032)
  9. 4.2.3 Global Sufentanil Citrate Injection Sales Market Share by Type (2021-2032)
  10. 4.3 Global Sufentanil Citrate Injection Revenue by Type
  11. 4.3.1 Global Sufentanil Citrate Injection Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sufentanil Citrate Injection Revenue by Type (2021-2032)
  13. 4.3.3 Global Sufentanil Citrate Injection Revenue Market Share by Type (2021-2032)
5 Sufentanil Citrate Injection Market by Application
  1. 5.1 Sufentanil Citrate Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Sufentanil Citrate Injection Sales by Application
  6. 5.2.1 Global Sufentanil Citrate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sufentanil Citrate Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Sufentanil Citrate Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sufentanil Citrate Injection Revenue by Application
  10. 5.3.1 Global Sufentanil Citrate Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sufentanil Citrate Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Sufentanil Citrate Injection Revenue Market Share by Application (2021-2032)
6 Global Sufentanil Citrate Injection Sales by Region
  1. 6.1 Global Sufentanil Citrate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sufentanil Citrate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Sufentanil Citrate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Sufentanil Citrate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sufentanil Citrate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sufentanil Citrate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sufentanil Citrate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sufentanil Citrate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sufentanil Citrate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sufentanil Citrate Injection Revenue by Region
  1. 7.1 Global Sufentanil Citrate Injection Revenue by Region
  2. 7.1.1 Global Sufentanil Citrate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sufentanil Citrate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Sufentanil Citrate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Sufentanil Citrate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sufentanil Citrate Injection Revenue (2021-2032)
  8. 7.2.2 North America Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sufentanil Citrate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sufentanil Citrate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sufentanil Citrate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sufentanil Citrate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Sufentanil Citrate Injection Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 EuroCept B.V.
  8. 8.2.1 EuroCept B.V. Company Information
  9. 8.2.2 EuroCept B.V. Business Overview
  10. 8.2.3 EuroCept B.V. Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 EuroCept B.V. Sufentanil Citrate Injection Product Portfolio
  12. 8.2.5 EuroCept B.V. Recent Developments
  13. 8.3 hameln pharma gmbh
  14. 8.3.1 hameln pharma gmbh Company Information
  15. 8.3.2 hameln pharma gmbh Business Overview
  16. 8.3.3 hameln pharma gmbh Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 hameln pharma gmbh Sufentanil Citrate Injection Product Portfolio
  18. 8.3.5 hameln pharma gmbh Recent Developments
  19. 8.4 Hikma Pharmaceuticals USA
  20. 8.4.1 Hikma Pharmaceuticals USA Company Information
  21. 8.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 8.4.3 Hikma Pharmaceuticals USA Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Pharmaceuticals USA Sufentanil Citrate Injection Product Portfolio
  24. 8.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 8.5 IDT Biologika GmBH
  26. 8.5.1 IDT Biologika GmBH Company Information
  27. 8.5.2 IDT Biologika GmBH Business Overview
  28. 8.5.3 IDT Biologika GmBH Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 IDT Biologika GmBH Sufentanil Citrate Injection Product Portfolio
  30. 8.5.5 IDT Biologika GmBH Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Sufentanil Citrate Injection Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Piramal Critical Care Limited
  38. 8.7.1 Piramal Critical Care Limited Company Information
  39. 8.7.2 Piramal Critical Care Limited Business Overview
  40. 8.7.3 Piramal Critical Care Limited Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Piramal Critical Care Limited Sufentanil Citrate Injection Product Portfolio
  42. 8.7.5 Piramal Critical Care Limited Recent Developments
  43. 8.8 Nhwa Pharmaceutical
  44. 8.8.1 Nhwa Pharmaceutical Company Information
  45. 8.8.2 Nhwa Pharmaceutical Business Overview
  46. 8.8.3 Nhwa Pharmaceutical Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nhwa Pharmaceutical Sufentanil Citrate Injection Product Portfolio
  48. 8.8.5 Nhwa Pharmaceutical Recent Developments
  49. 8.9 Sinopharm
  50. 8.9.1 Sinopharm Company Information
  51. 8.9.2 Sinopharm Business Overview
  52. 8.9.3 Sinopharm Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sinopharm Sufentanil Citrate Injection Product Portfolio
  54. 8.9.5 Sinopharm Recent Developments
  55. 8.10 Humanwell Pharmaceutical
  56. 8.10.1 Humanwell Pharmaceutical Company Information
  57. 8.10.2 Humanwell Pharmaceutical Business Overview
  58. 8.10.3 Humanwell Pharmaceutical Sufentanil Citrate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Humanwell Pharmaceutical Sufentanil Citrate Injection Product Portfolio
  60. 8.10.5 Humanwell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sufentanil Citrate Injection Value Chain Analysis
  2. 9.1.1 Sufentanil Citrate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sufentanil Citrate Injection Production Mode & Process
  6. 9.2 Sufentanil Citrate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sufentanil Citrate Injection Distributors
  9. 9.2.3 Sufentanil Citrate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research